Interstitial lung disease-related pneumomediastinum in COVID-19 patients

Pneumomediastinum in severe #COVID19 presentations could be due to a lung parenchymal retractive process generated by intense inflammation as in acute exacerbation of idiopathic pulmonary fibrosis or MDA-5 acute interstitial lung disease https://bit.ly/3qzBYMW

Detalles Bibliográficos
Autores principales: Blanc, Kim, Bonnet, Nicolas, Ouedraogo, Elise, Arnaout, Michel, Patout, Maxime, Tandjaoui-Lambiotte, Yacine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938049/
https://www.ncbi.nlm.nih.gov/pubmed/33718492
http://dx.doi.org/10.1183/23120541.00014-2021
_version_ 1783661522001592320
author Blanc, Kim
Bonnet, Nicolas
Ouedraogo, Elise
Arnaout, Michel
Patout, Maxime
Tandjaoui-Lambiotte, Yacine
author_facet Blanc, Kim
Bonnet, Nicolas
Ouedraogo, Elise
Arnaout, Michel
Patout, Maxime
Tandjaoui-Lambiotte, Yacine
author_sort Blanc, Kim
collection PubMed
description Pneumomediastinum in severe #COVID19 presentations could be due to a lung parenchymal retractive process generated by intense inflammation as in acute exacerbation of idiopathic pulmonary fibrosis or MDA-5 acute interstitial lung disease https://bit.ly/3qzBYMW
format Online
Article
Text
id pubmed-7938049
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-79380492021-03-12 Interstitial lung disease-related pneumomediastinum in COVID-19 patients Blanc, Kim Bonnet, Nicolas Ouedraogo, Elise Arnaout, Michel Patout, Maxime Tandjaoui-Lambiotte, Yacine ERJ Open Res Correspondence Pneumomediastinum in severe #COVID19 presentations could be due to a lung parenchymal retractive process generated by intense inflammation as in acute exacerbation of idiopathic pulmonary fibrosis or MDA-5 acute interstitial lung disease https://bit.ly/3qzBYMW European Respiratory Society 2021-03-08 /pmc/articles/PMC7938049/ /pubmed/33718492 http://dx.doi.org/10.1183/23120541.00014-2021 Text en Copyright ©The authors 2021 http://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Correspondence
Blanc, Kim
Bonnet, Nicolas
Ouedraogo, Elise
Arnaout, Michel
Patout, Maxime
Tandjaoui-Lambiotte, Yacine
Interstitial lung disease-related pneumomediastinum in COVID-19 patients
title Interstitial lung disease-related pneumomediastinum in COVID-19 patients
title_full Interstitial lung disease-related pneumomediastinum in COVID-19 patients
title_fullStr Interstitial lung disease-related pneumomediastinum in COVID-19 patients
title_full_unstemmed Interstitial lung disease-related pneumomediastinum in COVID-19 patients
title_short Interstitial lung disease-related pneumomediastinum in COVID-19 patients
title_sort interstitial lung disease-related pneumomediastinum in covid-19 patients
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938049/
https://www.ncbi.nlm.nih.gov/pubmed/33718492
http://dx.doi.org/10.1183/23120541.00014-2021
work_keys_str_mv AT blanckim interstitiallungdiseaserelatedpneumomediastinumincovid19patients
AT bonnetnicolas interstitiallungdiseaserelatedpneumomediastinumincovid19patients
AT ouedraogoelise interstitiallungdiseaserelatedpneumomediastinumincovid19patients
AT arnaoutmichel interstitiallungdiseaserelatedpneumomediastinumincovid19patients
AT patoutmaxime interstitiallungdiseaserelatedpneumomediastinumincovid19patients
AT tandjaouilambiotteyacine interstitiallungdiseaserelatedpneumomediastinumincovid19patients

Ejemplares similares